Changes of NLF in Serum of Long COVID Patients

See also
Status	Clinical Trial	Phase
Completed	`NCT04571021` - Implementation of the Individual Danish Emergency Process Triage	N/A
Recruiting	`NCT06102655` - Effect and Mechanism of Jiajian Guishen Formulation on Premature Ovarian Insufficiency Based on Metabolomics	Early Phase 1
Completed	`NCT06259383` - Oral Ivermectin for Chikungunya Viral Infection	Phase 3
Recruiting	`NCT06109337` - Immunoprofilling of Peripheral Blood Mononuclear Cells in Children With Attention Deficit/Hyperactivity Disorder

See also

Status

Clinical Trial

Phase

Completed

NCT04571021 - Implementation of the Individual Danish Emergency Process Triage

N/A

Recruiting

NCT06102655 - Effect and Mechanism of Jiajian Guishen Formulation on Premature Ovarian Insufficiency Based on Metabolomics

Early Phase 1

Completed

NCT06259383 - Oral Ivermectin for Chikungunya Viral Infection

Phase 3

Recruiting

NCT06109337 - Immunoprofilling of Peripheral Blood Mononuclear Cells in Children With Attention Deficit/Hyperactivity Disorder

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05060692
Study type	Observational
Source	University Hospital, Bonn
Contact
Status	Completed
Phase
Start date	June 1, 2020
Completion date	November 1, 2021

Changes of NLF in Serum of Long COVID Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms